542 related articles for article (PubMed ID: 12558800)
1. A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway.
Kimura N; Tokunaga C; Dalal S; Richardson C; Yoshino K; Hara K; Kemp BE; Witters LA; Mimura O; Yonezawa K
Genes Cells; 2003 Jan; 8(1):65-79. PubMed ID: 12558800
[TBL] [Abstract][Full Text] [Related]
2. 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol suppresses UV-Induced MMP-1 expression through AMPK-mediated mTOR inhibition as a downstream of the PKA-LKB1 pathway.
Shin DJ; Kim JE; Lim TG; Jeong EH; Park G; Kang NJ; Park JS; Yeom MH; Oh DK; Bode AM; Dong Z; Lee HJ; Lee KW
J Cell Biochem; 2014 Oct; 115(10):1702-11. PubMed ID: 24821673
[TBL] [Abstract][Full Text] [Related]
3. Insulin signalling downstream of protein kinase B is potentiated by 5'AMP-activated protein kinase in rat hearts in vivo.
Longnus SL; Ségalen C; Giudicelli J; Sajan MP; Farese RV; Van Obberghen E
Diabetologia; 2005 Dec; 48(12):2591-601. PubMed ID: 16283248
[TBL] [Abstract][Full Text] [Related]
4. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.
Bolster DR; Crozier SJ; Kimball SR; Jefferson LS
J Biol Chem; 2002 Jul; 277(27):23977-80. PubMed ID: 11997383
[TBL] [Abstract][Full Text] [Related]
5. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
[TBL] [Abstract][Full Text] [Related]
6. Extracellular ATP-induced proliferation of adventitial fibroblasts requires phosphoinositide 3-kinase, Akt, mammalian target of rapamycin, and p70 S6 kinase signaling pathways.
Gerasimovskaya EV; Tucker DA; Weiser-Evans M; Wenzlau JM; Klemm DJ; Banks M; Stenmark KR
J Biol Chem; 2005 Jan; 280(3):1838-48. PubMed ID: 15522879
[TBL] [Abstract][Full Text] [Related]
7. Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells.
Baumann P; Mandl-Weber S; Emmerich B; Straka C; Schmidmaier R
Exp Cell Res; 2007 Oct; 313(16):3592-603. PubMed ID: 17669398
[TBL] [Abstract][Full Text] [Related]
8. Mechanical stretch activates mammalian target of rapamycin and AMP-activated protein kinase pathways in skeletal muscle cells.
Nakai N; Kawano F; Nakata K
Mol Cell Biochem; 2015 Aug; 406(1-2):285-92. PubMed ID: 25971373
[TBL] [Abstract][Full Text] [Related]
9. Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status.
Cheng SW; Fryer LG; Carling D; Shepherd PR
J Biol Chem; 2004 Apr; 279(16):15719-22. PubMed ID: 14970221
[TBL] [Abstract][Full Text] [Related]
10. Role of adenosine 5'-monophosphate-activated protein kinase subunits in skeletal muscle mammalian target of rapamycin signaling.
Deshmukh AS; Treebak JT; Long YC; Viollet B; Wojtaszewski JF; Zierath JR
Mol Endocrinol; 2008 May; 22(5):1105-12. PubMed ID: 18276828
[TBL] [Abstract][Full Text] [Related]
11. Activation of the cardiac mTOR/p70(S6K) pathway by leucine requires PDK1 and correlates with PRAS40 phosphorylation.
Sanchez Canedo C; Demeulder B; Ginion A; Bayascas JR; Balligand JL; Alessi DR; Vanoverschelde JL; Beauloye C; Hue L; Bertrand L
Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E761-9. PubMed ID: 20051528
[TBL] [Abstract][Full Text] [Related]
12. The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK/mTOR/P70S6K signaling pathway.
Miao XY; Gu ZY; Liu P; Hu Y; Li L; Gong YP; Shu H; Liu Y; Li CL
Peptides; 2013 Jan; 39():71-9. PubMed ID: 23116613
[TBL] [Abstract][Full Text] [Related]
13. Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells.
Caligiuri A; Bertolani C; Guerra CT; Aleffi S; Galastri S; Trappoliere M; Vizzutti F; Gelmini S; Laffi G; Pinzani M; Marra F
Hepatology; 2008 Feb; 47(2):668-76. PubMed ID: 18098312
[TBL] [Abstract][Full Text] [Related]
14. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes.
Pham PT; Heydrick SJ; Fox HL; Kimball SR; Jefferson LS; Lynch CJ
J Cell Biochem; 2000 Sep; 79(3):427-41. PubMed ID: 10972980
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1.
El-Chaâr D; Gagnon A; Sorisky A
Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836
[TBL] [Abstract][Full Text] [Related]
16. Repression of protein synthesis and mTOR signaling in rat liver mediated by the AMPK activator aminoimidazole carboxamide ribonucleoside.
Reiter AK; Bolster DR; Crozier SJ; Kimball SR; Jefferson LS
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E980-8. PubMed ID: 15613684
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
[TBL] [Abstract][Full Text] [Related]
18. AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.
Thomson DM; Fick CA; Gordon SE
J Appl Physiol (1985); 2008 Mar; 104(3):625-32. PubMed ID: 18187610
[TBL] [Abstract][Full Text] [Related]
19. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB.
Varma S; Khandelwal RL
Biochim Biophys Acta; 2007 Jan; 1770(1):71-8. PubMed ID: 16952420
[TBL] [Abstract][Full Text] [Related]
20. Ultraviolet-induced phosphorylation of p70(S6K) at Thr(389) and Thr(421)/Ser(424) involves hydrogen peroxide and mammalian target of rapamycin but not Akt and atypical protein kinase C.
Huang C; Li J; Ke Q; Leonard SS; Jiang BH; Zhong XS; Costa M; Castranova V; Shi X
Cancer Res; 2002 Oct; 62(20):5689-97. PubMed ID: 12384526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
